This interactive half-day virtual course equips healthcare professionals with a comprehensive understanding of Heavy Menstrual Bleeding (HMB). The session focuses on causes, underlying aetiology, and current management strategies, providing practical, evidence-based knowledge to support effective diagnosis, treatment, and patient care.

Led by experienced clinicians, the course reviews the latest guidelines and best practice recommendations to optimise care for women experiencing HMB, ensuring participants gain the confidence and skills needed to make a meaningful impact on patient outcomes.

This course is ideal for clinicians working in primary care, women’s health, or anyone involved in the diagnosis and management of menstrual disorders.

Learning outcomes:

• Define Heavy Menstrual Bleeding (HMB)
  • Understand the clinical definition of HMB, its prevalence, and the impact on women's physical and mental health.
• Identify Causes and Aetiology of HMB
  • Recognise common and less common causes, including hormonal, structural, and systemic factors. Differentiate between primary and secondary HMB, exploring conditions such as fibroids, adenomyosis, endometrial polyps, and bleeding disorders.
• Evaluate and Diagnose HMB
  • Review the essential history-taking and examination components required to assess HMB effectively. Understand the diagnostic tools and investigations necessary to rule out serious underlying pathology, including ultrasound, blood tests
• Understand and Apply Current Management Options
  • Explore pharmacological treatments, including NSAIDs, tranexamic acid, hormonal therapy, and the use of intrauterine systems (IUS). Discuss non-pharmacological interventions and surgical options, from endometrial ablation to hysterectomy, with a focus on patient suitability and preference.
• Counsel Patients with a Compassionate and Individualised Approach
  • Develop strategies for empathetic communication, addressing patient concerns around treatment side effects, lifestyle impact, and fertility. Explore the importance of shared decision-making to align patient values with treatment choices.
• Stay Informed with Guidelines and Emerging Research
  • Review relevant guidelines, including those from NICE and other leading bodies, and discuss recent developments in the management of HMB